Calculating IOL power for children

Article

Determining the optimal IOL power for children is as much an art as a science.

The ultimate goal of paediatric IOL power selection is to provide a manageable course of refraction between IOL implantation and adulthood with the best possible adult visual acuity.

In adults, every millimetre of error in axial length measurement translates into about 2.5 D error. In children - who typically have short eyes of 20 mm or less - every millimetre of error in axial length translates into about 3.75 D error. That difference in effect has a direct impact on how axial length is measured.

Contact versus immersion

Immersion ultrasound measurements are the standard of care in adults, Dr Trivedi explained.

Ophthalmic surgeons recognize that physical contact between the ultrasound probe and the cornea can result in corneal depression and an artificially shortened axial length measurement.

Multiple studies have shown that immersion A-scan measurement eliminates corneal compression and produces more accurate axial length measurements compared with contact biometry.

An informal survey of paediatric ophthalmologists found that 82% use the contact ultrasound method to measure paediatric eyes.

Dr Trivedi reported data from a prospective study that compared contact and immersion ultrasound and the resulting IOL errors. Axial length measurements using contact ultrasound were 0.27 mm shorter compared with the same eyes measured with immersion ultrasound (p < 0.001).

The resulting IOL power needed for emmetropia was significantly different, with 28.62 D for contact and 27.63 for immersion (p < 0.001).

"If axial length measured by the contact technique is used, it would have resulted in the use of an average 1 D stronger IOL power than is actually required," Dr Trivedi said. "This can lead to induced myopia in the postoperative refraction.

"If possible, use immersion A-scan. Use the measurements from the scan with the best waveform - the highest peaks with a perpendicular retinal spike," she said. "If you must use applanation biometry, rely on the measurement with the greatest anterior chamber depth."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.